Replies to post #137264 on Innovation Pharmaceuticals Inc (IPIX)

[Ernesto]

It's entirely possible. More frequent dosing combined with a chemo agent or radiation will likely amplify and clarify the results considerably.

Remember from the Phase 2 PR, Kevetrin + 30mg Docetaxel resulted in 6/10 mice having their tumor reduced to unmeasurable size. It's possible the other 3 or 4 had significant reduction or at least stabilization. Coming anywhere near these results in a Phase 2 would give a clear result and a clear protocol which would yield a much stronger case for breakthrough designation.